Víctor González-Delgado

11PUBLICATIONS
16CO-AUTHORS
Major global burdens of diseaseMolecular targetsNgā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Toxicology (incl. clinical toxicology)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 31, 2026
Effectiveness and Safety of Janus Kinase Inhibitors in Adults Aged ≥ 50 Years With Moderate-To-Severe Atopic Dermatitis and Substantial Cardiovascular Comorbidity: A Multicenter Real-World Study.

Joan Ceravalls, Ignasi Figueras-Nart, Javier Melgosa Ramos

|Oct 23, 2025
Multicenter Retrospective Case Series on the Real-World Experience With Sonidegib for the Management of Gorlin Syndrome.

Gemma Pérez-Pastor, Dario Perosanz Lobo, Cristina Ciudad Blanco

|Apr 16, 2025
Effectiveness and Safety of Upadacitinib in Adults Older Than 50 Years With Moderate-To-Severe Atopic Dermatitis: A Multicenter Study.

Francisco Javier Melgosa Ramos, Lorena Vila Cobreros, Marta Galarreta Pascual

|May 13, 2024
Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group.

Antonio Sahuquillo-Torralba, Miguel Mansilla-Polo, Conrad Pujol-Marco

|Jan 17, 2024
Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort study.

Miguel A Lasheras-Pérez, Rodolfo D Palacios-Diaz, Víctor A González-Delgado

|Sep 25, 2023
Upadacitinib effectiveness in moderate-to-severe atopic dermatitis: A real-life multicentre and retrospective study.

F Javier Melgosa Ramos, Víctor González-Delgado, José María Sánchez Motilla

Pageof 2

Frequent Collaborators

3 joint publications

José M Martín

2 joint publications

Francisco Javier Melgosa Ramos

2 joint publications

Ricardo Ruíz-Villaverde

1 joint publications

Miguel A Lasheras-Pérez